Stocks and Investing Stocks and Investing
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017

Madhu Kumar Maintained (ALNY) at Strong Buy with Decreased Target to $220 on, Nov 8th, 2017


Published on 2024-10-26 00:43:14 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of B. Riley Securities, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Decreased Target from $240 to $220 on, Nov 8th, 2017.

Madhu has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Madhu's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $112 on, Thursday, September 21st, 2017
  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $101 on, Thursday, September 21st, 2017


These are the ratings of the 6 analyists that currently disagree with Madhu


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $151 on, Friday, November 3rd, 2017
  • Rahul Jasuja of "FBR Capital" Maintained at Strong Buy with Increased Target to $240 on, Thursday, November 2nd, 2017
  • Terence Flynn of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Monday, October 2nd, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $134 on, Friday, September 22nd, 2017
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $125 on, Thursday, September 21st, 2017
  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017